Sandbox:GE
Overview
Patient Evaluation
Initial Management
Shown below is an algorithm depicting the initial management of acute diarrhea is based on the 2001 IDSA practice guidelines for the management of infectious diarrhea.[1]
Characterize the symptoms: ❑ Onset Associated symptoms: Epidemiological factors: ❑ Travel ❑ Food (raw meat, eggs, shellfish, unpasteurized cheese or milk) ❑ Outbreaks ❑ Sexual history ❑ Day care attendance ❑ Previous evaluations ❑ Medications, radiation therapy or surgery ❑ Underlying medical condition (cancer, diabetes, hyperthyroidism or AIDS) | |||||||||||||||||||||||||||||||||||||||||
Examine the patient: ❑ Temperature | |||||||||||||||||||||||||||||||||||||||||
Assessment of volume status
† Some dehydration = At least two signs, including at least one key sign (*) are present. | |||||||||||||||||||||||||||||||||||||||||
No dehydration | Some dehydration | Severe dehydration | |||||||||||||||||||||||||||||||||||||||
Start altered diet
❑ Stop lactose products Can start oral rehydration therapy (ORT) for replacement of stool losses | ❑ Start IV fluids: Ringer lactate at 30ml/kg in the first 1/2hr and 70ml/kg for the next 2 1/2 hr, if unavailable use normal saline ❑ CBC ❑ Electrolytes ❑ Assess status every 15 mins until strong pulse felt and then every 1 hr | ||||||||||||||||||||||||||||||||||||||||
Patient stable and able to drink ❑ Start ORT at a volume of 100 mL/kg over 4 hour ❑ Calculate the continuing stool and emesis losses every hour for additional maintenance ORT therapy ❑ Reassess status every 4 hr | |||||||||||||||||||||||||||||||||||||||||
Hemodynamic stabilized Proceed to Diagnosis and Management | |||||||||||||||||||||||||||||||||||||||||
Diagnostic and Management approach
Passage of ≥3 unformed stools in 24 h + an enteric symptom (nausea, vomiting, abdominal pain/cramps, tenesmus, fecal urgency, moderate to severe flatulence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Watery diarrhea ± Vomiting | Dysenteric diarrhea (passage of grossly bloody stools) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mild Illness† | Moderate to Severe† | No or low-grade fever(≤100°F) | Severe illness† with fever≥(101°F) in a single case (not outbreak) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hydration only May use loperamide 4 mg initially to control stooling | Travel associated | Non travel associated | Non travel associated | Travel associated | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Antibiotic therapy | No or low-grade fever (≤100°F) | Fever (≥101°F) | Empiric treatment Azithromycin 1 g in single dose OR 500 mg once daily for 3 days | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
<72 h duration | ≥72 h duration | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loperamide therapy for 48 h | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Microbiologic assessment and appropriate treatment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Persistent diarrhea (14–30 days) should be worked up by culture and/or culture independent microbiologic assessment, then treatment with anti microbial agent directed to cause | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
†Illness severity:
- Severe: Total disability due to diarrhea;
- Moderate: Able to function but with forced change in activities due to illness;
- Mild: No change in activities
Classification
Gastroenteritis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Viral | Bacterial | Parasites | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common | Less Common | Common | Less Common | Helminthic | Protozoal | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ Rotaviruses ❑ Noroviruses ❑ Enteric Adenoviruses ❑ Astroviruses | ❑ Kobuviruses ❑ Enteroviruses ❑ Orthoreoviruses ❑ Toroviruses ❑ Coronaviruses (including SARS) ❑ Parvoviruses | Gram Positive | Gram Negative | Gram Positive | Gram Negative | {{{ D07 }}} | {{{ D08 }}} | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
{{{ E01 }}} | {{{ E02 }}} | {{{ E03 }}} | {{{ E04 }}} | {{{ E05 }}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
{{{ F01 }}} | {{{ F02 }}} | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Synopsis
Special consideration
General principles for treatment
Prevention
❑ E.Coli species
❑ Salmonella species
❑ Shigella
❑ Campilobacter
❑ Vibrio species|D04=❑ Bacillus cereus
❑ Bacteroids fragilis
❑ Aeromonas
❑ Staphylococcus aureus
- ↑ Guerrant RL, Van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV; et al. (2001). "Practice guidelines for the management of infectious diarrhea". Clin Infect Dis. 32 (3): 331–51. doi:10.1086/318514. PMID 11170940.